Dataset Information
Clinical relevance of inherited genetic differences in human tryptases: Hereditary alpha-tryptasemia and beyond.
Ontology highlight
ABSTRACT: Objective
To describe our current understanding of hereditary α-tryptasemia (HαT), how HαT fits into the evolutionary context of tryptases and contemporary framework of mast cell-associated disorders, and to discuss the future clinical and therapeutic landscape for symptomatic individuals with HαT.Data sources
Primary peer-reviewed literature.Study selections
Basic, clinical, and translational studies describing tryptase gene composition, generation, secretion, and elevation and the associated clinical impacts of HαT and treatment of such individuals were reviewed.Results
HαT is a common autosomal dominant genetic trait caused by increased TPSAB1 copy number encoding α-tryptase. Approximately 1 in 20 White individuals have HαT, making it by far the most common cause for elevated basal serum tryptase levels. Although many individuals with HαT may not manifest associated symptoms, the prevalence of HαT is increased in patients with clonal and nonclonal mast cell-associated disorders wherein it is linked to more prevalent and/or severe anaphylaxis and increased mast cell mediator-associated symptoms. Increased generation of mature α/β-tryptase heterotetramers, and their unique physiochemical properties, may be responsible for some of these clinical findings.Conclusion
HαT is a common modifier of mast cell-associated disorders and reactions. Nevertheless, whether HαT may be an independent cause of clinical phenotypes with which it has been associated remains unproven. Correct identification of HαT is critical to accurate interpretation of serum tryptase levels in the clinical evaluation of patients. Beyond HαT, we foresee tryptase genotyping as an important parameter in the standard workup of patients with mast cell-associated disorders and development of therapeutic modalities targeting these patients and associated clinical phenotypes.
SUBMITTER: Glover SC
PROVIDER: S-EPMC9413800 | biostudies-literature | 2021 Dec
REPOSITORIES: biostudies-literature
Publications
Clinical relevance of inherited genetic differences in human tryptases: Hereditary alpha-tryptasemia and beyond.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20210813 6
<h4>Objective</h4>To describe our current understanding of hereditary α-tryptasemia (HαT), how HαT fits into the evolutionary context of tryptases and contemporary framework of mast cell-associated disorders, and to discuss the future clinical and therapeutic landscape for symptomatic individuals with HαT.<h4>Data sources</h4>Primary peer-reviewed literature.<h4>Study selections</h4>Basic, clinical, and translational studies describing tryptase gene composition, generation, secretion, and elevat ...[more]